Fig. 2. Change in IPSS scores as a measure of treatment effectiveness

Slides:

Advertisements

Similar presentations

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Advertisements

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

WEEK 1 You have 10 seconds to name…

LUTS Audit Gopal Krishana Singh. Method Brownhills – Patients Searched all patient on medical treatment Looked at the notes to identify (recorded) – IPSS.

Fig. 3. (A) Bladder compliance and (B) volume of residual urine were evaluated by urodynamic study preoperatively, and at 1, 3, and 12 months after conventional.

The Effects of Growth Hormone and Sex Steroid on Lean Body Mass, Fat Mass, Muscle Strength, Cardiovascular Endurance and Adverse Events in Healthy Elderly.

Figure 1. Average percent change in heart rate.

A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold.

STANDARD ERROR OF SAMPLE

International Neurourology Journal 2015;19:

Volume 77, Issue 1, Pages (January 2011)

Tai Chi Exercise for Cancer-Related Fatigue in Patients With Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial Li-Li Zhang, RN, Su-Zhen.

Volume 18, Issue 4, Pages (June 2015)

Laser and Radiofrequency Ablation Study (LARA study): A Randomised Study Comparing Radiofrequency Ablation and Endovenous Laser Ablation (810nm) S.D.

Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms? Mark J. Speakman European Urology Supplements

Volume 17, Issue 8, Pages (December 2014)

International Neurourology Journal 2010;14:93-99

International Neurourology Journal 2011;15:92-96

Volume 67, Issue 1, Pages (January 2015)

عمل الطالبة : هايدى محمد عبد المنعم حسين

Volume 54, Issue 6, Pages (December 2008)

آشنايی با اصول و پايه های يک آزمايش

Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Steven A. Kaplan,

Volume 60, Issue 6, Pages (December 2011)

Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms? Mark J. Speakman European Urology Supplements

Volume 49, Issue 5, Pages (May 2006)

Rowland Illing European Urology Supplements

Volume 55, Issue 2, Pages (February 2009)

Volume 63, Issue 1, Pages (January 2013)

Volume 197, Issue 2, Pages S189-S197 (February 2017)

Volume 52, Issue 3, Pages (September 2007)

Volume 56, Issue 3, Pages (September 2009)

Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis Paolo Vercellini, M.D., Giussy Barbara, M.D., Edgardo Somigliana,

Mean change from baseline in (A) DAS28-4(ESR), (B) CDAI and (C) HAQ-DI

Rowland Illing European Urology Supplements

Tai Chi Exercise for Cancer-Related Fatigue in Patients With Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial Li-Li Zhang, RN, Su-Zhen.

Volume 61, Issue 3, Pages (March 2012)

The efficacy of 12 weeks non-surgical treatment for patients not eligible for total knee replacement: a randomized controlled trial with 1-year follow-up

Yuanshan Cui, Yong Zhang European Urology

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old P. Perrin,

The Impact of Pain Management on Quality of Life

Volume 50, Issue 3, Pages (September 2006)

Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea Shin Fukudo, Motoko Ida, Hiraku Akiho, Yoshihiro.

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Volume 54, Issue 6, Pages (December 2008)

Volume 53, Issue 6, Pages (June 2008)

What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice? François Desgrandchamps European Urology.

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

Emmanuel Chartier-Kastler, Kate Davidson European Urology Supplements

Martin Michel, Jean de la Rosette European Urology Supplements

(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.

3 Week A: May 1 – 19 3 Week B: May 22 – June 9

Change in LBM (%)‏ LD CD LD CD LD CD

Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms? Mark J. Speakman European Urology Supplements

Fig. 3. Reporter assay for the RS-ATL8 reporter cell line against shrimp extracts (A, B) RS-ATL8 cells were sensitized overnight with diluted pooled sera.

(G) Body mass index (BMI) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (G) Body mass index (BMI) values.

Technical Innovations and Patient Support in Radiation Oncology

Mean (SD) change from baseline to week 6 and week 54 in partial Mayo score (A), and the proportions of patients by severity grade for the (B) stool frequency.

(A) Urinary L-FABP (ULFABP) values in eight participants who had more than 5 µg/g creatinine (Cr) at the start of the study, at baseline and after treatment.

Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea Shin Fukudo, Motoko Ida, Hiraku Akiho, Yoshihiro.

Types of Errors And Error Analysis.

Figure 1. The proportion of CSBM responders over the 2-week treatment period (A), the proportion of SBM responders by ... Figure 1. The proportion of CSBM.

DAS28-CRP change from baseline over 24 weeks (TP1 per-protocol set) at baseline, the mean DAS28-CRP was 5.42 and 5.53 for GP2015 and ETN groups, respectively.

Least squares (LS) mean (SE) changes from baseline in (A) Cutaneous Lupus Erythematosus Disease Area and Severity Index activity scores and (B) Tender.

Primary outcome and patient reported secondary outcomes in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia receiving.

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial Eli O. Meltzer, MDa,

A1C at baseline and each maintenance month by treatment in the GEMINI trial, including the modified intention-to-treat population. A1C at baseline and.

(D) Systolic blood pressure (BP) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. . (D) Systolic blood pressure.

(A) Mean (95% CI) change and (B) mean percentage (SE) change in enthesitis scores (Leeds Enthesitis Index, SPARCC Enthesitis Index, and MASES) from baseline.

Presentation transcript:

Fig. 2. Change in IPSS scores as a measure of treatment effectiveness Fig. 2. Change in IPSS scores as a measure of treatment effectiveness. (A) Mean IPSS total score and subscores for the 12-week (N=265) and 24-week surveillance groups (N=44). Mean±SD is shown. (B) Mean change from baseline on all IPSS scores. Error bars represent±SE. ***p<0.0001. IPSS: International Prostate Symptom Score, SD: standard deviation, QoL: quality of life, SE: standard error. Fig. 2. Change in IPSS scores as a measure of treatment effectiveness. (A) Mean IPSS total score and subscores for the 12-week (N=265) and 24-week surveillance groups (N=44). Mean±SD is shown. (B) Mean change from baseline on all IPSS scores. Error bars represent±SE. ***p<0.0001. IPSS: International Prostate Symptom Score… World J Mens Health. 2018 May;36(2):161-170. https://doi.org/10.5534/wjmh.17017